NTR-1011 demonstrated a favorable safety, tolerability, and immunogenicity profile across multiple dose levels of intravenous ...
A study published in the Journal of Bioresources and Bioproducts establishes quantitative structure-activity relationships ...
The results are transforming how scholars understand human history. By analysing parchment, researchers are uncovering ...
Experiencing joint pain or restricted movement? A deficiency in essential nutrients may play a role. Here’s how anjeer may help.
Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.
Morning Overview on MSN
Scientists identify a brain-aging protein and a way to counter its effects
Researchers at the University of California, San Francisco have identified an iron-storing protein called ferritin light ...
Master ultra-high-throughput screening principles. Learn how advanced automation and miniaturization accelerate drug ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
An investigational medicine that addresses the genetic root cause of BAG3 DCM, AFTX-201 is being evaluated as a treatment for BAG3 DCM in the UPBEAT trial in the U.S. and Canada AFTX-201 is designed ...
Affinia Therapeutics gets Health Canada approval to initiate UPBEAT phase 1/2 trial to investigate AFTX-201 to treat BAG3-associated DCM: Waltham, Massachusetts Tuesday, April 7, ...
What is the market size of the Bio-Ethanol Market? The global Bio-Ethanol market was valued at USD 134680 million in 2025 and is anticipated to reach USD 232210 million by 2032, at a CAGR of 8.2% from ...
Hassabis says Google DeepMind had to return to startup roots and 'be scrappier' after the Brain merger, running Isomorphic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results